Vinge advises in conjunction with sale of mySafety Group

January 16, 2023 M&A

Vinge has advised Litorina and other shareholders of mySafety Group AB in conjunction with the sale of the company shares to a consortium consisting of Empir Group AB and a number of current and previous senior officers within the mySafety group.

mySafety invented ID protection insurance in 2008 and has been the Nordic market leader and inventor in the fraud and ID protection insurance field since then. In 2021, mySafety had an approximate turnover of MSEK 352 with an EBITDA of approximately MSEK 38.

Vinge’s team primarily consisted of Johan Winnerblad, Per Kling, Gunilla Nyman and Ellinore Boström Andersson.


Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023